Publication: 220

Publication: 220

High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.

PubMed

DOI

Google Scholar

Citation:: Leuk Lymphoma vol 49 (6) 1202-5

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: TRP
Primary Committee:: Correl Sci NOS
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: Raymond Lai Nancy L Bartlett John R Mackey Sin-Ho Jung Jeffrey L Johnson James R Cook Dan Jones Carol E Cass James D Young Jonathan Said Bruce Cheson Eric D Hsi

Networks:

Study: CALGB-59804
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords:: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Deoxycytidine, Doxorubicin, Equilibrative Nucleoside Transporter 1, Female, Hodgkin Disease, Humans, Liposomes, Male, Middle Aged, Neoplasm Recurrence, Local, Reed-Sternberg Cells, Survival Rate, Treatment Failure, Vinblastine